Distalmotion seeks FDA clearance for DEXTER use

​Distalmotion has submitted a 510(k) application to the FDA seeking clearance to use the DEXTER robotic surgery system for sacrocolpopexy, sacrocervicopexy and endometriosis resection.

The post Distalmotion seeks FDA clearance for DEXTER use appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Alpha Cognition begins enrolment in RESOLVE Phase IV trial for Zunveyl
Altaris to acquire Simulations Plus in $375m all-cash deal
Distalmotion secures second FDA gynaecology clearance for DEXTER system
Takeda reports pivotal data from FirstLight and RadiantLight trials
FDA approves Bayer’s Ambelvist contrast agent

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us